A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally

References

• World Health Organization. Medical management of abortion. Geneva: World Health Organization; 2018.
   Google Scholar
• World Health Organization. WHO recommendations on self-care interventions: self-management of medical abortion (WHO/SRH/20.11). Geneva: World Health Organization; 2020.
   Google Scholar
• ReproAction. Understanding and advocating for self-managed abortion; [cited 2020 Sept. 24]. Available from: https://reproaction.org/campaign/self-managed-abortion/
   Google Scholar
• Gynuity Health Projects. Map of mifepristone approvals; [cited 2020 Sept. 24]. Available from: https://gynuity.org/assets/resources/mapmife-en.pdf
   Google Scholar
• Gynuity Health Projects. Map of misoprostol approvals; [cited 2020 Sept. 24]. Available from: https://gynuity.org/assets/resources/mapmiso__en.pdf
   Google Scholar
• Doran F, Nancarrow S. Barriers and facilitators of access to first-trimester abortion services for women in the developed world: a systematic review. J Fam Plann Reprod Health Care. 2015;41:170–180.
   PubMed Web of Science ®Google Scholar
• Winikoff B, Sheldon W. Use of medicines changing the face of abortion. Int Perspect Sex Reprod Health. 2012;38(3):164–166.
   PubMed Web of Science ®Google Scholar
• Diamond-Smith N, Percher J, Saxena M, et al. Knowledge, provision of information and barriers to high quality medication abortion provision by pharmacists in Uttar Pradesh, India. BMC Health Serv Res. 2019;19(1):476.
   Web of Science ®Google Scholar
• World Health Organization (WHO). Essential medicines list application mifepristone–misoprostol for medical abortion; [cited 2020 Sept. 24]. Available from: https://www.who.int/selection_medicines/committees/expert/22/applications/s22.1_mifepristone-misoprostol.pdf?ua=1
   Google Scholar
• International Planned Parenthood Federation. Medical abortion commodities database; [cited 2020 Sept. 24]. Available from: https://www.medab.org/
   Google Scholar
• Footman K, Keenan K, Reiss K, et al. Medical abortion provision by pharmacies and drug sellers in low- and middle-income countries: A systematic review. Stud Fam Plann. 2018;49(1):57–70.
   PubMed Web of Science ®Google Scholar
• MSH (Management Sciences for Health). International medical products price guide. 2015 ed. Medford, MA: MSH; 2016.
   Google Scholar
• World Bank. World Bank country income’s classification status; [cited 2020 Sept. 24]. Available from: https://blogs.worldbank.org/opendata/new-country-classifications-income-level-2017-2018
   Google Scholar
• Center for Reproductive Rights. The world's abortion laws map 2014; [cited 2020 Sept. 24]. Available from: https://www.reproductiverights.org/sites/default/files/documents/AbortionMap2014.PDF
   Google Scholar
• UNFPA. Quality assurance policy for reproductive health medicines, November, 2012. Available from: https://www.unfpa.org/resources/reproductive-health-medicines.
   Google Scholar
• Murtagh C, Wells E, Raymond EG, et al. Exploring the feasibility of obtaining mifepristone and misoprostol from the internet. Contraception. 2018;97:287–291.
   Web of Science ®Google Scholar
• Hall P. Quality of medicines: quality of misoprostol products. WHO Drug Inf. 2016;30:1–109.
   Google Scholar
• Mann Global Health. Landscape assessment: leveraging the role of national distributors to increase access to medical abortion combi-packs in Africa. Report to the Reproductive Health Supplies Coalition, January 2019 Available from: https://www.rhsupplies.org/uploads/tx_rhscpublications/Landscape_Assessment_Combi-Packs_RHSC_01.pdf.
   Google Scholar
• Singh S, Remez L, Sedgh G, et al. Abortion worldwide 2017: uneven progress and unequal access. New York: Guttmacher Institute, 2018.
   Google Scholar
• Reiss K, Footman K, Burke E, et al. Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study. BMC Pregnancy Childbirth. 2017;17(1):211.
   Google Scholar
• Ganle JK, Busia NT, Maya E. Availability and prescription of misoprostol for medical abortion in community pharmacies and associated factors in Accra, Ghana. Int J Gynaecol Obstet. 2019;144(2):167–173.
   Web of Science ®Google Scholar
• Weaver G, Schiavon R, Collado ME, et al. Misoprostol knowledge and distribution in Mexico city after the change in abortion law: a survey of pharmacy staff. BMJ Sex Reprod Health. 2020;46:46–50.
   Web of Science ®Google Scholar
• Raymond EG, Harrison MS, Weaver MA. Efficacy of misoprostol alone for first-trimester medical abortion: A systematic review. Obstet Gynecol. 2019;133(1):137–147.
   PubMed Web of Science ®Google Scholar
• Schocken C. Business case: investing in production of high-quality misoprostol for low-resource settings, Jhpiego; 2014.
   Google Scholar